CLINICAL_TRIALS
trial_result
· 2021-11-17
Clinical Trial Update: A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers [Phase 1]
Summary
Phase 1 crossover study assessing three intranasal formulations of M207 with zolmitriptan in healthy volunteers; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zosano Pharma Corporation | Conditions: Migraine | Phase 1 | Status: COMPLETED | Results posted: 2021-11-17